Drugs / ISH0613
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07516639 | Apr → Dec 2026 expected | systemic lupus erythematosus | SUNHO（China）BioPharmaceutical CO., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ISH0613 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07516639 ↗ |
| Route | Intravenous | “single intravenous infusion of either ISH0613 or placebo” NCT07516639 ↗ |